Ascendis Pharma A/S Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Ascendis Pharma A/S's estimated annual revenue is currently $63.1M per year.
- Ascendis Pharma A/S received $115.0M in venture funding in October 2016.
- Ascendis Pharma A/S's estimated revenue per employee is $155,000
- Ascendis Pharma A/S's total funding is $190.9M.
- Ascendis Pharma A/S has 407 Employees.
- Ascendis Pharma A/S grew their employee count by 45% last year.
- Ascendis Pharma A/S currently has 1 job openings.
What Is Ascendis Pharma A/S?
Ascendis Pharma is a biotechnology company applying its innovative prodrug technology to build a leading, fully integrated rare disease company. Our science-driven and passionate people are advancing a pipeline of endocrinology programs focused on making a difference in patients lives. By utilizing our TransCon technology with clinically validated parent drugs, we create new therapies with potential for best-in-class efficacy, safety and/or convenience. Ascendis Pharma is headquartered in Copenhagen, Denmark, maintains an office in Palo Alto, California, and has research and development facilities in Heidelberg, Germany, and Copenhagen, Denmark.keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power